TRCT
BITI

Tower Research Capital (TRC)’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Tower Research Capital (TRC)’s Portfolio BITI Stock Details BITI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-597
Closed -$16K – 5459
2016
Q1 		$16K Buy
+597
New +$13.9K ﹤0.01% 1541
2015
Q4 		– Sell
-1,453
Closed -$19K – 5567
2015
Q3 		$19K Buy
1,453
+555
+62% +$9.76K ﹤0.01% 1800
2015
Q2 		$18K Buy
+898
New +$18.7K ﹤0.01% 2222

Tower Research Capital (TRC)'s BITI Position: Q2 2016 in Review

Tower Research Capital (TRC) sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q2 2016, closing a stake of 597 shares — an estimated $16K sold.

Tower Research Capital (TRC) first reported a position in BITI in Q2 2015 and held it in 3 quarters. The position peaked at $19K in Q3 2015. 0 funds tracked by Wall St. Rank hold BITI as of Q2 2016.

  • Tower Research Capital (TRC) reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q2 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 597 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q2 2016, an estimated $16K.
  • Tower Research Capital (TRC) first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q2 2015 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $19K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q2 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.